英文名称:NCI-H226 [H226]
货号:GCL-0396
价格: ¥1600.00 ¥1600.00
产品详情
产品信息
物种 | Human |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
冻存条件 |
冻存液:无血清非程序冻存液(GPB180438)/通用血清型程序冻存液(GPB180436) 温度:液氮 |
培养方案A(默认) |
生长培养基:RPMI-1640[GPM150110]+10% FBS[163210]+1% P/S[GPB180120] 培养条件: 温度:37℃ |
推荐传代比例 | 1:3-1:4 |
推荐换液频率 | 2-3次/周 |
参考资料(来源文献)
背景描述 | NCI-H226 [H226]细胞是于1980年分离建立的。 |
年龄(性别) | Age unspecified |
组织来源 | 肺;源自转移部位:胸腔积液 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 肺癌细胞 |
生物安全等级 | BSL-1 |
保藏机构 | ATCC; CRL-5826 |
相关文献
-
期刊:EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
DOI:10.1016/j.ejps.2024.106894
影响因子:4.3
相关产品: RPMI-1640 Medium, Fetal Bovine Serum, NCI-H226 [H226] Cells Line, THP-1 Cells Line
-
期刊:NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
DOI:10.1007/s00210-024-03328-9
影响因子:3.1
相关产品: Calu-1 Cells Line, A549 [A-549] Cells Line, NCI-H1975 Cells Line, NCI-H226 [H226] Cells Line, BEAS-2B Cells Line
-
Increased LOXL2 expression is related to poor prognosis in lung squamous cell carcinoma(2024)
期刊:Journal of Thoracic Disease
影响因子:2.1
-
GPRC5A promotes paclitaxel resistance and glucose content in NSCLC(2024)
期刊:ANTI-CANCER DRUGS
DOI:10.1097/CAD.0000000000001610
影响因子:1.8
相关产品: NCI-H1299 Cells Line, NCI-H226 [H226] Cells Line, NCI-H1703 Cells Line
-
期刊:JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
DOI:10.1186/s13046-023-02875-y
影响因子:11.3
相关产品: A549 [A-549] Cells Line, NCI-H1299 Cells Line, NCI-H292 Cells Line, NCI-H23 Cells Line, NCI-H1703 Cells Line, NCI-H226 [H226] Cells Line, BEAS-2B Cells Line
-
TRIM26 promotes non-small cell lung cancer survival by inducing PBX1 degradation(2023)
期刊:International Journal of Biological Sciences
影响因子:9.200
-
期刊:Cell Reports
DOI:10.1016/j.celrep.2023.113362
影响因子:8.8
-
期刊:Cancer Cell International
DOI:10.1186/s12935-023-03109-z
影响因子:5.8
-
期刊:JOURNAL OF ETHNOPHARMACOLOGY
影响因子:5.4
相关产品: NCI-H226 [H226] Cells Line, NCI-H520 Cells Line, HCC827 Cells Line
-
期刊:Frontiers in Oncology
影响因子:4.7